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Abstract: Array-based sensor ‘chemical nose/tongue’ platforms 
are inspired by the mammalian olfactory system.  Multiple 
sensor elements in these devices selectively interact with target 
analytes, producing a distinct pattern of response and enabling 
analyte identification. This approach offers unique opportunities 
relative to ‘traditional’ highly specific sensor elements such as 
antibodies. Array-based sensors excel at distinguishing small 
changes in complex mixtures, and this capability is being 
leveraged for chemical biology studies and clinical pathology, 
enabled by a diverse toolkit of new molecular, bioconjugate and 
nanomaterial technologies. Innovation in the design and analysis 
of arrays provides a robust set of tools for advancing biomedical 
goals, including precision medicine.   
1. Introduction 
 Sensors are an integral part of everyday life, monitoring 
our health and wellbeing and maintaining our safety. Chemical 
sensors are an important subclass that use recognition elements 
and transducers to detect and quantify important molecules. But 
beyond the latest smart technologies, perhaps the most powerful 
chemical-focused sensory tool that we rely upon to keep us safe 
and healthy is our olfactory system – smell.    
 A ‘chemical nose’ sensor is broadly defined as an array-
based system that uses synthetic molecules and/or materials to 
mimic the mammalian olfactory systems.1 The synthetic model 
of the natural systems can be created and tuned to specific 
sensing challenges. In this review, we use the term ‘chemical 
nose’ to describe the array-based sensing approach. However, it 
is conceptually equivalent between ‘chemical nose’ and 
‘chemical tongues or E-tongues’. Unlike specific sensing, the 
chemical nose works on the principle of selective binding 
between an analyte and an array of cross-reactive receptors to 
generate distinct responses for each analyte. The responses 
can then be read out and linked back to the analyte through 
pattern recognition. Therefore, the same chemical nose can 
detect multiple analytes with relatively few sensor elements, by 
returning multiple distinct patterns from the array.  
 A major difference between chemical nose sensing and 
more traditional specific sensing is that chemical nose uses the 
simultaneous interaction of multiple analytes with multiple 
sensor elements to recognize the overall changes to the make-
up of complex mixtures, rather than identifying specific elements 
within them.2  Thus, this array-based approach is particularly 
powerful in sensing complex bioanalytes. The data-rich outputs 
of array-based sensing methods are becoming widely adopted 
by the analytical community, due to the increase in capabilities 
with statistical and cheminformatic techniques in analysis, as 
well as the recognition that many complex sensing challenges 
cannot be solved with conventional analytical tools.3 
 Array-based sensors have now been applied in a broad 
range of applications including explosives4 and volatile-organic 
compound (VOC) detection, 5  environmental monitoring 6  and 
anti-counterfeiting technologies.7 Several thorough reviews have 
been written, particularly by the groups of Walt and Suslick, and 
detail the history and chemical space of the technology.8,2a   
 In this review we focus on the emerging use of chemical 
noses in biology and medicine, where their performance in 
complex mixtures demonstrates their unique and useful 
capabilities.9  We will first outline briefly the design and operation 
of cross-reactive arrays for sensing. We will examine the 
particular materials utilized for the platforms, and the statistical 
analyses used to realize their output. In the following sections, 
we will review recent studies where profiling of biological 
samples has been achieved to great effect. In particular, we will 
focus on two key areas - protein sensing and cell biology. In 
each case we will examine the potential application of sensor 
arrays in biomedical R&D and translation to the clinic, focusing 
on oncology as well as other pathologies. Finally, we will offer 
some insights on future directions for chemical noses in 
biological sensing. 
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2. Design, Construction and Analysis of 
Arrays  
2.1. Designing arrays for Biosensing – the Basic 
Components  
 There are two essential processes involved in biosensing: 
analyte recognition and signal transduction. For array-based 
sensing a final component is required, namely pattern 
recognition. Each recognition element in the sensor array is 
designed to ensure that interactions will occur with the analytes 
being studied (selectivity). However, because the recognition 
elements are not specific to one analyte, cross-reactivity also 
occurs between receptors.  The recognition event (or lack 
thereof) between analyte and each receptor in the array then 
needs to be transduced to a measurable outcome such as an 
electric, fluorescent, or colorimetric signal. Finally, the response 
from each recognition element must be collected and combined 
for each analyte and then analyzed using statistical 
methodologies for classification or identification.  
2.2. Building Arrays for Biosensing – Material Choices  
 Chemical-nose arrays for biosensing require the ability to 
interface synthetic organic and inorganic materials with 
biomolecules. Purely biological array elements often suffer from 
poor signal transduction or instability under ambient conditions. 
By careful choice of materials and integration of synthetic 
elements, more reliable and stable arrays can be created.  
 Nanomaterials are particularly useful for biosensing due to 
their unique physiochemical properties that can be used for 
novel recognition and transduction processes.10 Nanoparticles 
have highly tunable size and surface functionalities where one or 
multiple interacting ligands can serve as the recognition 
elements.11  This synthetic control enables the attachment of 
custom recognition elements in a modular fashion. Coupled with 
the high surface-to-volume ratio of smaller size, nanoparticles 
provide more interaction sites leading to less sensor material 
required and enhanced sensitivity. 12  Furthermore, the 
optoelectronic properties of many nanoparticles allow them to 
double as (part of) the transduction system, by simultaneously 
acting as a platform for a recognition element and providing an 
electromagnetic output that can be induced or modified on a 
sensor binding event. Examples include the plasmon-induced 
fluorescence quenching commonly observed with gold 
nanoparticles (AuNPs), the dependence of the plasmon band 
position of AuNPs on size and aggregation,13 and the tunable 
fluorescence emission of metal nanoclusters.14 
 Macromolecules provide many of the same attributes as 
nanomaterials, by functioning both as a recognition element and 
platform for the reporter. Synthetic macromolecules, including 
conjugated and non-conjugated polymers and macrocycles have 
been integrated into sensor arrays15 as well as systems utilizing 
biological polymers (peptides and nucleotides). 16  Conjugated 
polymers have been developed extensively for array-based 
sensing due to their bright, tunable emission, with a key 
requirement being the development of water-soluble variants for 
interfacing with biological systems.17 Biological polymers have 
been applied to exploit their inherent biological compatibility and 
specificity and further engineered to introduce the desired cross-
reactivity. Examples include the use of synthetic peptides as 
generalized substrates for enzyme sensing.18 Through design of 
a peptides with differing sequences, the peptides can interact 
with many different members of a particular family of enzymes 
(e.g clotting factors). The small differences in activity that occur 
between each enzyme and each of the peptides generates the 
cross-reactivity needed to distinguish between members of that 
enzyme family. 19  In addition, oligopeptides have also 
demonstrated utility in cell membrane sensing, with designed 
patterns of charge and hydrophobicity/hydrophilicity.20  
 Finally, small molecule fluorophores, fluorescent proteins 
and molecular chromophores are also good candidates for 
creating sensor arrays, either in conjunction with polymers or 
nanoparticles as for most of the examples discussed in this 
review, or as arrays in their own right.6  
2.3. Transduction of the Recognition Event  
 Transduction in chemical noses has most commonly been 
achieved by colorimetric and fluorometric detection, although 
electrochemical read-out, 21  as well as spectroscopic 
fingerprinting techniques (Raman, 22  IR, 23  and chiral 
spectroscopy24) have also been applied. Recently, other less 
common examples of solution/solid phase biosensing arrays 
such as chemiluminescent 25 , SPR technique 26  and 
microcantilevers 27 have also been reported. Colorimetric 
detection has been achieved most simply with dye color 
changes on binding ions, small molecules and 
biomacromolecules.8,28 A second approach has been to use the 
strong plasmonic absorbance band of AuNPs. The red color of 
spherical AuNPs is sensitive to their surface modification and 
will red shift when particles aggregate or increase in size.29 By 
modifying the surface of the AuNPs with cross-reactive binding 
moieties, this selective color change effect can be induced with 
groups of analytes. Successful implementation of this 
transduction strategy has been demonstrated with detection of 
bacterial species,30 toxic metal ions,31 and proteins.32 Recently, a 
third style of colorimetric array has emerged, using opal-like 
photonic crystal structures that display strong color changes 
based on their chemistry and interaction with various analytes.33 
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Figure 1. An overview of chemical nose sensing – moving beyond N receptors 
for N analytes. (a) A traditional specific sensor and (b) a cross-reactive (but 
still selective) array-based sensor. In (a) one element can interact with one 
analyte transducing single responses with N receptors needed to measure N 
analytes. For (b), each element in a mixture interacts in different ways with a 
cross-reactive array. The transduction of the interactions leads to pattern 
generation for the combination of elements. The patterns are then processed, 
and it is possible to detect more analytes than there are elements.  
 
Fluorometric transduction is widely applied in biosensor 
arrays thanks to its high sensitivity, and widespread adoption in 
biology.34 Fluorometric sensing can either be turn-on or turn-off, 
caused by separating a quencher and fluorophore or bringing 
them together with the analyte respectively. 35  AuNPs in 
particular have found broad application as quenchers for such 
systems.36  Another option is to employ a fluorescence color 
change mediated by energy transfer (often Forster resonance 
energy transfer – FRET). Using FRET strategies, several 
research groups have designed selective sensor arrays.37 A final 
fluorometric transduction mechanism is via the use of 
environmentally responsive dyes. Many fluorophores such as 
Nile Red, merocyanines, and BODIPY display fluorescence 
intensity and emission wavelength shifts on changes to the 
polarity, protic strength or viscosity of their local environment, 
enabling their use in cross-reactive arrays.38 
 One key advantage of fluorometric sensing over 
colorimetric is the ability to multiplex several different color 
outputs in a single measurement – three or more fluorophores 
can be interrogated in a single sensor array, without the need for 
physical separation. 39  This leads to high-throughput sensor 
arrays that require much less sample to analyze.40    
  
2.4. Statistical Data Analysis Methods   
 The conversion of patterns generated by cross-reactive 
arrays into interpretable data is at the heart of the array-based 
sensor, i.e. ‘classification’. Classification can be achieved in the 
case of specific single-element sensor by visual recognition, 
such as in the case of a pregnancy-test style assay or antibody-
based ELISA (enzyme-linked immunosorbent assay).41 However, 
in cross-reactive arrays the patterns can be harder to interpret 
visually and so generally some degree of computer processing 
is required. To achieve classification with a sensor array, the 
transduced signals are tabulated alongside any information on 
the sample composition (what ‘class’ it fits e.g. a cell line, a 
protein family or a disease state) so that patterns from unknown 
samples can be cross-referenced with samples of a known class. 
The aim is to reduce many tens or hundreds of values in the 
transduced signals, derived from each element for the cross-
reactive array, into a simpler, smaller vector that summarizes the 
most distinguishing features of the pattern, and can be easily 
compared with other samples for the purpose of analysis.42 The 
statistical methodologies that are applied for this purpose have 
been reviewed previously,8,43 so we will only briefly outline some 
possibilities here.   
 Two families of classification algorithms exist - 
unsupervised learning and supervised learning. Unsupervised 
techniques attempt to process the data presented without any 
class information from the user, in an attempt to find elements of 
the array that best separate the data (Principle Component 
Analysis - PCA) or find data that naturally cluster together 
(Hierarchical Clustering Analysis - HCA).44 These techniques 
work well for identifying trends in large array datasets and for 
identifying which sensing elements in a multi-sensor array 
contribute the most to the discrimination of analytes.  
 Supervised techniques are a crucial part of array-based 
sensing, enabling the sensing readout from the transduced 
signals. A primary ‘training’ dataset from samples of known class 
is used to create an algorithm that can organize the samples into 
one of the defined classes. Once this model has been trained it 
can be tested, using a secondary, independent set of data, 
withholding the class information from the model. The success 
of the algorithm at classifying this second dataset gives an 
indicator for the accuracy of the model at identifying true 
unknown samples. In the simplest cases (e.g. Linear 
Discriminant Analysis - LDA) an unknown is classified into one 
of the known groupings based on simple linear fits. By applying 
more advanced supervised algorithms, more complex 
discriminatory patterns can be generated that not only identify 
unknown samples that are a match to one of the original training 
data classes, but also those that are similar but different to any 
of the original classes, or samples that fall well outside any 
known class.20b Examples of such algorithms include support 
vector machines (SVM),44 or artificial neural networks (ANN),22 
but a detailed discussion of these machine learning techniques 
is beyond the scope of this review.  
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Figure 2. Protein detection in serum using array-based sensors. (a) Structure 
of cationic Au-NPs. (b) Sensing scheme of AuNP-GFP array with serum 
proteins, where the addition of proteins causes differential release of GFP. (c) 
Differentiation of five major serum proteins in spiked human serum samples. 
Adapted with permission from Reference [57]. Copyright 2009 Nature 
Publishing Group 
3. Array-based Sensors for Biomedical 
Applications  
 Since the advent of reliable enzymatic and antibody panels, 
arrays have been applied to biomedical sciences for the 
simultaneous detection of multiple analytes using specific 
receptors, resulting in lectin,45 aptamer,46 and affimer47 arrays. 
However, the specificity of such systems, while theoretically high, 
may often be much lower than assumed, particularly where an 
unpredictable cross-reactivity might occur.48 Recent work on a 
direct comparison between two genetic marker panels using 
specific DNA sensing has observed significant variability 
between independent methods purporting to measure the same 
DNA sequences. Furthermore, the diagnoses inferred from the 
DNA biomarker results were contradicted by the outcome of a 
well-known protein biomarker assay performed on the same 
samples. 49  Other issues including the stability of biological 
sensor constructs (such as antibodies) and complicated 
attachment of transduction elements hinder translation of 
laboratory techniques to the clinic.50  
 In comparison, selective array-based sensors operating in 
a biological environment face a different, but very particular set 
of challenges. For example, the need for water-solubility, and 
stability conferred by careful materials selection, as discussed in 
Section 2. One approach to this challenge is to utilize 
transducers linked to engineered biomaterials that confer the 
desirable degree of bio-specificity while maintaining the 
essential cross-reactivity. 51  Through this strategy, successful 
biosensor arrays can be created with high sensitivity. These 
arrays are able to detect small changes in the composition of 
complex mixture without the need for prior biomarker discovery 
and isolation steps.52 
3.1. From Buffer to Biological Matrices for Protein Detection  
 The first demonstrations of arrays for biomedical science 
focused on the detection and discrimination of individual proteins. 
Much of the work combines a fluorogenic sensor with a variety 
of recognition elements that create differential fluorescence 
patterns when bound/not bound to the target protein in solution.  
As an excellent proof-of-concept, a wide range of different 
proteins have been successfully detected using fluorescent 
metal complexes, 53  nanoclusters, 54  quantum dots, 55  or 
colorimetric gold nanoparticle aggregation.32 However, it needs 
to be noted that while many examples exist of array-based 
sensing in buffer or water, 56  fewer groups have tested their 
systems in biologically relevant media.  
 In addressing this challenge, biological matrices such as 
serum have been incorporated into sensing protocols. An early 
pioneer work detected analyte proteins in ‘spiked’ serum through 
an AuNP and fluorescent protein array.57 The positively charged 
headgroups on the AuNPs electrostatically attracted a negative 
fluorescent protein (FP) and quenched its fluorescence. If the FP 
was displaced by another negatively charged protein (e.g. serum 
albumin, transferrin or fibrinogen) then the FP lit up. By tuning 
the AuNP surface functionality, the strength of the AuNP-FP and 
analyte interactions was varied to create a sensor array.  Using 
the AuNP array, five major serum proteins could be 
discriminated at various concentrations and in various ratios 
(Figure 2). 
 In other examples, two or more fluorescent metal 
nanocluster cores with different surface functionality have been 
used as the fluorometric recognition/transduction element, rather 
than rely on a two-part NP/FP combination. The binding of the 
protein to the nanocluster modulates both the fluorescence 
intensity and the emission wavelength (the color) giving two 
channels to be probed per sensor element, improving the 
discrimination (Figure 3). 58  Work by Ouyang and co-workers 
used two of these color-changing particles to discriminate 
between proteins in buffer, but also serum collected from 
patients, some diagnosed with hepatoma. Ouyang and 
coworkers have also applied their fluorescent particles to a 1D 
PAGE assay for protein biomarker detection.59 Recently, Xu et al.  
reported a near infrared sensor array of which dual ligand co-
functionalized gold nanoclusters were decorated with amino 
acids. This platform not only discriminated proteins at nanomolar 
concentrations but also serum samples collected from different 
stages of breast cancer patients as well as healthy people.60 
Similar sensing strategies have also been tested with human 
urine samples as well as disease sera from patients. 61 
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Figure 3. Demonstration of the use of fluorescent gold nanoclusters derived from collagen (Col) and Macerozyme-10 (Mac) in protein sensing. (a) Differential 
changes in optical signals upon interaction with target proteins in aqueous solution - lysozyme (Lys), human serum albumin (HSA), egg white albumin (EA), 
pepsin (Pep), hemoglobin (Hb), trypsin (Try), catalase (CAT), and transferrin (Tf). (b) Fluorescence emission shifts in both intensity and wavelength upon binding 
with select proteins. Adapted with permission from Reference [58]. Copyright 2014 American Chemical Society.  
 
 
Figure 4. Discrimination of proteins using a multifunctional small molecule bearing responsive fluorophores. (a) Schematic illustration of sensor construction. 3 
protein binding moieties (EA- ethacrynic amide, MT – marimastat and Apt – a DNA aptamer) and 4 fluorophores (indicated by *s – nitrobenzoxadiazole, nile red, 
cyanine 5.5 and cyanine 7) were added to a cis-amino proline scaffold to form the sensor. (b) Fluorescence patterns generated by sensors after adding tested 
proteins. (c) LDA classification of enriched proteins in urine samples for different glutathione-S-transferases (GSTs), matrix metalloproteases (MMPs) and platelet-
derived growth factors (PDGFs). Adapted from Reference [64]. Copyright 2017 Nature Publishing Group. 
 
3.2. Targeting Specific Biological Challenges in Chemical 
Biology and Pathology   
 
 Moving beyond nanomaterials, synthetic macromolecules 
have been used to discriminate proteins in a variety of settings 
with biological relevance.62 Many of these works also include 
non-specific biological domains as part of their sensor elements 
to tailor the cross-reactivity of their arrays to the targets of 
interest.  
 Combinatorial fluorescent molecular probes are emerging 
to be powerful in generating pattern recognition arrays. 63 
Recently, Margulies and coworkers reported an elegant multipart 
fluorescent probe featuring three fluorophores including a DNA 
aptamer hairpin, and two additional protein recognition sites 
based on small molecules (shown in Figure 4).64 The protein 
recognition sites were selected for known non-specific binding 
interactions with disease associated protein families, such as 
glutathione-S-transferases (GSTs), matrix metalloproteases 
(MMPs) and platelet-derived growth factors (PDGFs). Upon 
binding different variants of the three classes of proteins, the 
fluorophores responded through changes in color and intensity, 
due to solvatochromic and FRET processes. The probe was 
further applied to sense target proteins in human urine as 
biomarkers for various kidney and liver diseases. It performed 
well, even in the presence of competing serum proteins. 
Interestingly, the multiplexed probe was also demonstrated as a 
sensor operating inside cells for exploring inhibition pathways. 
The strategy of utilizing molecular fluorescent probes has also 
been implemented to detect and differentiate amyloid beta 
aggregates that play a crucial role in Alzheimer’s disease.65 
 Another approach to small molecule probes was 
demonstrated by Waters and coworkers, who applied a 
combinatorial supramolecular approach to sense post-
translational modifications of histones.66 They created a dynamic 
sensor array by combining a thiolated-aromatic, bridging two 
aromatic molecules to form a supramolecular pocket. This 
pocket was then mixed with a dye (lucigenin) to form a host-
guest complex. The working principle of such sensor is that the 
histone can bind the supramolecular sensor, causing 
displacement of the dye, and a corresponding fluorescence 
change. Different modifications of the histone affected the 
binding strength between the sensor and histone, resulting in 
changes to the amount of dye displaced and fluorescent pattern 
generation. The combinatorial sensor also distinguished 
between different post-translational methylation, acetylation and 
phosphorylation patterns.
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Figure 5. Liver fibrosis diagnosis using array-based sensing strategy. (a) Schematic illustration of polymer-based array sensing for serum proteome to distinguish 
between fibrotic and nonfibrotic patients. (b) Polymer structure featuring three responsive fluorophores. (c) Potential working principle of environmental polymers. 
Adapted with permission from Reference [68]. Copyright 2017 Wiley-VCH.  
 
 
 Anslyn et al.  monitored the post-translational 
phosphorylation and subsequent activation of kinases in cell 
lysates as a tool for studying the kinase signaling and apoptosis 
pathways 67 . As with the work of Waters, Anslyn created a 
dynamic supramolecular array with three components: a 
hydrogen-bonding molecule, a Zn2+ complex mounted in various 
configurations on a three-armed supramolecular receptor 
complex and two cross-reactive peptide recognition sequences 
for their target. This three-armed structure hosted a coumarin 
dye for transduction. With a seven-sensor array created from this 
combinatorial library, the activity of four MAP kinases could be 
monitored. More importantly, the authors also demonstrated that 
in identical cell lines triggered to undergo different kinase 
signaling pathways, differing phosphorylation could be 
‘fingerprinted’ with the sensor array.    
 In a recent work we have extended the use of array-based 
sensing using polymers into diagnostics. As shown in Figure 5, a 
responsive sensor array was generated that responded to 
proteins through solvatochromism and energy transfer using 
three dyes on a polymer backbone and measured the 
fluorometric response of the dye mixed with human serum. The 
sensor array was tested against blood samples from a cohort of 
healthy patients and those with liver fibrosis (n=60), and 
discrimination was possible, with 80% accuracy versus the 
standard test.68 This study signposts the potential applications of 
array-based serum diagnostics for early warning systems or 
classification of diseases that present as serum proteome 
modification. 
 
 
4. Applications of Arrays for Phenotyping 
Cells  
  
 Beyond sensing proteins in cell lysates (demonstrated in 
Section 3), the complex surface composition of intact living cells 
makes them excellent targets for array-based sensing. In 
particular, cell phenotyping is emerging as an important tool for 
understanding and treating cancers, with rapid assessment of 
cell-behavior in response to environmental stimuli. Cell sensing 
is a broad area, where both prokaryotes (specifically bacteria) 
and eukaryotes have been classified. Since bacterial sensing 
has been recently reviewed69, in this section of review, we will 
focus on eukaryotic cells with highlights of recent advances and 
applications in oncology. 
 
Figure 6. Breast cancer cell line sensing with gold nanoclusters. (a) 
Schematic illustration of the dual-ligand functionalized gold nanoclusters 
sensor array. (a) (b) LDA classification of 10 breast cancer cell lines. Adapted 
with permission from Reference [72]. Copyright 2018 Elsevier.  
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4.1. Cancer Detection and Progression   
 Early studies on sensing cancer cells looked to provide 
diagnostic information through cell surface profiles.70  Sensors 
were constructed to detect the differences between non-
cancerous, cancerous and metastatic cell lines. We applied a 
similar approach to the protein sensing work discussed in 
Section 3 (Figure 2), leveraging the fluorescence turn-on 
interaction between cationic AuNPs with different surface 
functionalities and anionic fluorescent polymers or proteins to 
create arrays capable of distinguishing the three categories.71  
 Other materials such as gold nanoclusters have also been 
explored for cancer cell surface sensing. Tao and coworkers 
have recently reported separation of ten triple-negative breast 
cancer cell lines from multiple patients, with varying degrees of 
metastasis, using dual-ligand functionalized gold nanoclusters 
(Figure 6).72 Anslyn and coworkers created an array from nine 
thiazole-orange labelled peptides, tuned to interact with various 
cell-surface features, and a piece of double-stranded DNA that 
intercalated the thaizole orange modifying the fluorescence of 
the array in-situ on the cell surface. Multivariate analysis on the 
array data showed that it could distinguish eight cancer cell lines 
form different parts of the body. Most interestingly, by applying a 
support vector machine (SVM) to their data, a ninth cell line not 
included in the test set could be detected and differentiated.20b  
 Wu et al. recently built an electrical impedance array 
based on non-specific functionalization of graphene electrodes 
that not only differentiated differing cancer cell lines but could 
also detect a model for circulating tumor cells (CTCs) at low 
concentrations, i.e MCF-7 spiked into matrices containing 
peripheral blood mononuclear cells.73 CTCs are strongly linked 
with metastasis and poor prognoses. Once CTCs exit the 
primary tumor site and enter the bloodstream they become hard 
to detect by conventional antibody-based techniques. 74  This 
study represents a step towards using signature-based sensing 
in challenging oncological scenarios.  
As noted in all the works above, cancer is not a static 
disease. Each stage is associated with significant geno- and 
phenotypic changes in the cells. Much of the work described has 
focused on cells with significant genotypic differences; 
differentiating different cancerous cell lines or between 
metastatic and non-metastatic cell lines. However, in many 
areas, arrays are tested against multiple cell lines with differing 
genetic backgrounds as well as varying degrees of metastasis. 
The changes arising from the different genetic background will 
also contribute to sensor response, potentially overwhelming 
any detection of metastasis. Thus, it is important to also test 
against isogenic cell lines with minimum genetic diversity to 
isolate these cell-line features.  
   
4.2. Beyond Cell Classification – High Content Screening of 
Chemotherapeutics 
 A very different application of array-based cell sensing 
from diagnostics is to monitor the response and death of cells 
when exposed to an environmental stimulus such as a drug. 
Rapid determination of drug mechanism is a key step in 
therapeutic discovery,75 and cell-based screening methods are 
increasingly used to facilitate the process.76 However, many of 
the cell-based assays are limited by the multi-step processing of 
cells prior to analyses, and an incomplete understanding of 
biomolecular pathways for correlating drug and response.77 To 
demonstrate the utility of array-based sensors in this area, a 
cationic benzyl-functionalized AuNP was complexed with three 
different anionic FPs. When exposed to cells, the AuNP interacts 
with cell surfaces and releases FPs into solution, turning-on 
fluorescent signals for profiling cell surfaces. The cell lines 
studied were exposed to one of 15 different anti-cancer drugs 
featuring seven different drug mechanisms. The sensing results 
showed distinct patterns for each treated cell line, which could 
be further clustered into the hypothesized drug mechanism, and 
novel drugging routes were also elucidated (Figure 7).78 
 
 
Figure 7. The use of array-based sensor in profiling drug mechanisms of chemotherapeutics. (a) Complexation of sensor array. (b) Workflow for drug screening 
using nanoparticle-based arrays. (c) Classification of 7 different drug mechanisms. Adapted with permission from Reference [78]. Copyright 2015 Nature 
Publishing Group. 
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5. Summary and Outlook   
 Cross-reactive arrays provide unique capabilities for 
identifying changes in complex biological mixtures. The 
hypothesis-free nature of these systems facilitates exploration of 
sensing space and has already been used to discriminate 
analytes difficult or impossible to differentiate using standard 
approaches.  The ‘nose’ approach has been used to ‘fingerprint’ 
proteins, cell types and even the presence or absence of 
disease. Although highly specific biological arrays will provide a 
cornerstone of bioanalysis and pathology, it is clear that 
selective cross-reactive arrays are playing an increasingly 
important role in biomedicine.  
   
The performance of cross-reactive sensor arrays continues 
to improve, as more advanced designs and improved statistical 
analyses are brought to bear on challenging biological problems. 
Fundamental discoveries in pathology, cell biology and 
physiology have been discussed here and research is now 
looking to address three challenging areas. 
 The first major challenge is to combine the outputs of the 
sensor array with advances in highly specific sensors, utilizing 
antibodies, aptamers and other engineered affinity proteins (e.g. 
affimers) to understand exactly what the arrays are responding 
to. In this way biomarker discovery can lead to better arrays and 
arrays can lead to better biomarker discovery.  
 A second challenge is to improve the quality of data and 
analysis. Once an array has demonstrated its potential for e.g. 
fingerprinting a disease, larger scale screening and rigorous 
repetition will be required to translate the technology to clinic. 
With larger datasets, more robust statistical analysis can be 
employed, and more reliable conclusions can be drawn. The 
statistics applied to arrays are becoming better understood by 
the community, and it is promising to see advanced techniques 
such as SVM becoming popular – however care should be taken 
to apply the correct classification tool and avoid violating key 
assumptions of the classification algorithms used (see reference 
79 for a discussion of this with respect to LDA and SVM).80 
 Finally, it is time to begin moving array-based sensing out 
of the lab.81 Suslick et al. have had success at creating hand 
held devices for their colorimetric arrays, 82  but the solvated 
arrays used in many of the biosensing examples above will 
require careful engineering of microfluidic polydimethylsiloxane 
and paper-based systems. 83  This development, coupled with 
advances in mobile reading technologies,84 will lead to simple, 
robust point-of-care diagnostics. 
 Specific array-based sensors have been part of analytical 
science for a long time, but now selective cross-reactive 
‘chemical nose’ sensors are making real headway. We have 
illustrated here that biology and medicine will be areas where 
these arrays can become a highly disruptive technology. By 
moving beyond tried and tested sensing challenges and working 
with bioscientists and clinicians, the ‘chemical nose’ has a 
promising future in biomedical technologies.  
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